HRP20110208T1 - Farmaceutska formulacija za liječenje gornjeg probavnog sustava - Google Patents
Farmaceutska formulacija za liječenje gornjeg probavnog sustava Download PDFInfo
- Publication number
- HRP20110208T1 HRP20110208T1 HR20110208T HRP20110208T HRP20110208T1 HR P20110208 T1 HRP20110208 T1 HR P20110208T1 HR 20110208 T HR20110208 T HR 20110208T HR P20110208 T HRP20110208 T HR P20110208T HR P20110208 T1 HRP20110208 T1 HR P20110208T1
- Authority
- HR
- Croatia
- Prior art keywords
- effervescent tablet
- upper digestive
- digestive system
- inflammatory changes
- weight
- Prior art date
Links
- 210000001035 gastrointestinal tract Anatomy 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000007938 effervescent tablet Substances 0.000 claims abstract 12
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims abstract 3
- 229960004436 budesonide Drugs 0.000 claims abstract 3
- 230000000694 effects Effects 0.000 claims abstract 2
- 210000002249 digestive system Anatomy 0.000 claims 6
- 230000002757 inflammatory effect Effects 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 3
- 210000000214 mouth Anatomy 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 2
- 239000002324 mouth wash Substances 0.000 claims 2
- 229940051866 mouthwash Drugs 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010064212 Eosinophilic oesophagitis Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010028116 Mucosal inflammation Diseases 0.000 claims 1
- 201000010927 Mucositis Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 claims 1
- 229960000878 docusate sodium Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 201000000708 eosinophilic esophagitis Diseases 0.000 claims 1
- -1 hydrogencarbonate compound Chemical class 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002458 infectious effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000003800 pharynx Anatomy 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08013091A EP2151235B1 (de) | 2008-07-21 | 2008-07-21 | Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110208T1 true HRP20110208T1 (hr) | 2011-04-30 |
Family
ID=39951664
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110208T HRP20110208T1 (hr) | 2008-07-21 | 2011-03-23 | Farmaceutska formulacija za liječenje gornjeg probavnog sustava |
| HRP20130171AT HRP20130171T1 (hr) | 2008-07-21 | 2013-02-27 | Farmaceutska formulacija za lijeäśenje gornjeg probavnog sustava |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130171AT HRP20130171T1 (hr) | 2008-07-21 | 2013-02-27 | Farmaceutska formulacija za lijeäśenje gornjeg probavnog sustava |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US8580300B2 (pt) |
| EP (2) | EP2151235B1 (pt) |
| JP (2) | JP5616889B2 (pt) |
| CN (1) | CN102159196B (pt) |
| AT (1) | ATE498396T1 (pt) |
| AU (1) | AU2009273361B2 (pt) |
| CA (1) | CA2731312C (pt) |
| CY (2) | CY1111878T1 (pt) |
| DE (1) | DE502008002621D1 (pt) |
| DK (2) | DK2151235T3 (pt) |
| EA (1) | EA018465B1 (pt) |
| ES (2) | ES2358158T3 (pt) |
| HK (1) | HK1149907A1 (pt) |
| HR (2) | HRP20110208T1 (pt) |
| IL (1) | IL210779A (pt) |
| ME (2) | ME01256B (pt) |
| NZ (1) | NZ590593A (pt) |
| PL (2) | PL2151235T3 (pt) |
| PT (2) | PT2151235E (pt) |
| RS (2) | RS51649B (pt) |
| SI (2) | SI2151235T1 (pt) |
| UA (1) | UA100759C2 (pt) |
| WO (1) | WO2010009961A1 (pt) |
| ZA (1) | ZA201100283B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| ATE251449T1 (de) | 1999-06-14 | 2003-10-15 | Cosmo Spa | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| DE502008002621D1 (de) * | 2008-07-21 | 2011-03-31 | Falk Pharma Gmbh | Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes |
| WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| CN107252488A (zh) | 2009-10-01 | 2017-10-17 | 艾戴尔医药公司 | 口服给予的皮质类固醇组合物 |
| US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| WO2015034678A2 (en) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis |
| SI2886108T2 (sl) * | 2013-12-23 | 2023-02-28 | Dr. Falk Pharma Gmbh | Optimizirana farmacevtska formulacija za zdravljenje vnetnih sprememb požiralnika |
| TWI777515B (zh) | 2016-08-18 | 2022-09-11 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4332394A1 (de) | 1993-09-23 | 1995-03-30 | Falk Pharma Gmbh | Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung |
| US5639475A (en) * | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
| US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| US5807577A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| US5807578A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| GB9611364D0 (en) * | 1996-05-31 | 1996-08-07 | Smithkline Beecham Plc | Composition |
| US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
| JP3818789B2 (ja) * | 1999-02-18 | 2006-09-06 | 三菱化学フーズ株式会社 | 易崩壊性錠剤 |
| WO2003006629A1 (fr) | 2001-07-11 | 2003-01-23 | Toshirou Sekine | Procede et dispositif de culture de microbes de photosynthese |
| WO2003026610A2 (en) * | 2001-09-25 | 2003-04-03 | Ranbaxy Laboratories Limited | Process for the preparation of fast dissolving dosage form |
| WO2003043518A2 (en) * | 2001-11-20 | 2003-05-30 | Dmi Biosciences, Inc. | Methods and products for oral care |
| US20030215502A1 (en) * | 2002-03-20 | 2003-11-20 | Elan Pharma International Limited | Fast dissolving dosage forms having reduced friability |
| SE0401031D0 (sv) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
| US20060013873A1 (en) * | 2004-07-16 | 2006-01-19 | Chih-Chiang Yang | Bioadhesive dosage form of steroids |
| US20070071817A1 (en) * | 2005-09-26 | 2007-03-29 | Phyzz, Inc. | Effervescent oral care compositions and method of use |
| CA2642641A1 (en) * | 2006-02-15 | 2007-08-23 | Tika Laekemedel Ab | Stable corticosteroid mixtures |
| PL2170348T3 (pl) * | 2007-06-22 | 2017-01-31 | Dompé Farmaceutici S.P.A. | Tabletki musujące do zastosowania wziewnego |
| EP2205213A2 (en) * | 2007-10-01 | 2010-07-14 | Laboratorios Lesvi, S.L. | Orodispersible tablets |
| DE502008002621D1 (de) * | 2008-07-21 | 2011-03-31 | Falk Pharma Gmbh | Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes |
| WO2010144865A2 (en) * | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
-
2008
- 2008-07-21 DE DE502008002621T patent/DE502008002621D1/de active Active
- 2008-07-21 AT AT08013091T patent/ATE498396T1/de active
- 2008-07-21 SI SI200830187T patent/SI2151235T1/sl unknown
- 2008-07-21 EP EP08013091A patent/EP2151235B1/de active Active
- 2008-07-21 RS RS20110100A patent/RS51649B/en unknown
- 2008-07-21 ME MEP-2011-46A patent/ME01256B/me unknown
- 2008-07-21 PT PT08013091T patent/PT2151235E/pt unknown
- 2008-07-21 PL PL08013091T patent/PL2151235T3/pl unknown
- 2008-07-21 ES ES08013091T patent/ES2358158T3/es active Active
- 2008-07-21 DK DK08013091.7T patent/DK2151235T3/da active
-
2009
- 2009-02-07 UA UAA201101686A patent/UA100759C2/uk unknown
- 2009-07-02 AU AU2009273361A patent/AU2009273361B2/en not_active Ceased
- 2009-07-02 DK DK09800023.5T patent/DK2306988T3/da active
- 2009-07-02 ES ES09800023T patent/ES2399321T3/es active Active
- 2009-07-02 PT PT98000235T patent/PT2306988E/pt unknown
- 2009-07-02 NZ NZ590593A patent/NZ590593A/en unknown
- 2009-07-02 RS RS20130071A patent/RS52662B/en unknown
- 2009-07-02 JP JP2011519101A patent/JP5616889B2/ja not_active Expired - Fee Related
- 2009-07-02 CA CA2731312A patent/CA2731312C/en not_active Expired - Fee Related
- 2009-07-02 WO PCT/EP2009/058320 patent/WO2010009961A1/de active Application Filing
- 2009-07-02 SI SI200930502T patent/SI2306988T1/sl unknown
- 2009-07-02 EA EA201100229A patent/EA018465B1/ru not_active IP Right Cessation
- 2009-07-02 ME MEP-2013-22A patent/ME01494B/me unknown
- 2009-07-02 EP EP09800023A patent/EP2306988B1/de not_active Revoked
- 2009-07-02 PL PL09800023T patent/PL2306988T3/pl unknown
- 2009-07-02 US US13/054,844 patent/US8580300B2/en not_active Expired - Fee Related
- 2009-07-02 CN CN2009801358800A patent/CN102159196B/zh not_active Expired - Fee Related
-
2011
- 2011-01-11 ZA ZA2011/00283A patent/ZA201100283B/en unknown
- 2011-01-20 IL IL210779A patent/IL210779A/en active IP Right Grant
- 2011-03-11 CY CY20111100274T patent/CY1111878T1/el unknown
- 2011-03-23 HR HR20110208T patent/HRP20110208T1/hr unknown
- 2011-04-27 HK HK11104202.3A patent/HK1149907A1/xx not_active IP Right Cessation
-
2013
- 2013-02-26 CY CY20131100174T patent/CY1113719T1/el unknown
- 2013-02-27 HR HRP20130171AT patent/HRP20130171T1/hr unknown
- 2013-10-23 US US14/061,578 patent/US20140079646A1/en not_active Abandoned
-
2014
- 2014-07-30 JP JP2014155149A patent/JP6209495B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110208T1 (hr) | Farmaceutska formulacija za liječenje gornjeg probavnog sustava | |
| BRPI0414311A (pt) | formas de dosagem de liberação controlada | |
| CO6150127A2 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
| JP2014221827A5 (pt) | ||
| UA108360C2 (uk) | Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині | |
| JP2012511034A5 (pt) | ||
| MX2008000087A (es) | Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5. | |
| AR069312A1 (es) | Composicion farmaceutica que comprende beta oxihidroxido de hierro en alta carga en forma adecuada para administarcion oral y que contiene al menos un hidrato de carbono y/o acido humico y su uso en el tratamiento de pacientes con hiperfosfatemia y con insuficiencia renal cronica , y procedimento pa | |
| MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
| JP2010518122A5 (pt) | ||
| JP2007506775A5 (pt) | ||
| JP2015038135A5 (pt) | ||
| HRP20100674T1 (hr) | Farmaceutski pripravak koji sadrzi omega-karboksiaril supstituirani difenil ureu za lijecenje raka | |
| KR20090057349A (ko) | 레보도파／칼비도파의 ２４시간의 장기간 장내투여 | |
| WO2011116139A3 (en) | Improved pharmaceutical compositions comprising cck- 8 and methods of delivery | |
| JP2014512390A5 (pt) | ||
| PE20040121A1 (es) | Formulaciones farmaceuticas de liberacion controlada del 5,8,14-triazatetraciclo [10.3.1.02,11.04.9]-hexadeca-2-(11),3,5,7,9-pentaeno | |
| HRP20120754T1 (hr) | Dozirni oblik koji sadrži pantoprazol kao aktivni sastojak | |
| WO2006072940A3 (en) | Controlled long acting release pharmaceutical preparation for use in the oral cavity | |
| HRP20180327T1 (hr) | Sredstva za uporabu u slučaju intolerancije na fruktozu | |
| RU2014115287A (ru) | Фармацевтическая композиция для перорального введения с маскированным вкусом и способ ее получения | |
| HRP20190550T1 (hr) | Formule i metode proizvodnje formulacija za upotrebu u pražnjenju debelog crijeva | |
| ES2716990T3 (es) | Formulación farmacéutica optimizada para el tratamiento de cambios inflamatorios del esófago | |
| NO20080244L (no) | Doseringsstyring for prasugrel | |
| ES2689919T3 (es) | Formulación farmacéutica multicapa |